Concepedia

Author

Hongbo Lu

The University of Texas MD Anderson Cancer Center

Also Known As

H Lu, H. Karen Lu, H. Lu, Hegang Lu, Hong-bo Lü, Hongbo Lu, Lu, H.

48

Publications

1.6K

Citations

16

H-Index

51

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterHouston MethodistSt. Jude Children's Research HospitalBaylor UniversityJuntendo University
HL

About

Hongbo Lu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

984

2

Cell Biology

8

8

666

3

Health Sciences

1

1

17

4

Allergy

1

1

198

5

Cellular Therapies

1

1

33

Hongbo Lu

×

15

Publications

1.4K

Citations

15

H-Index

YearCitations

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

Linhua Jin, Yoko Tabe, Sergej Konoplev,

Molecular Cancer Therapeutics

2008

204

Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone

Sara K. Custer, Manuela Neumann, Hongbo Lu,

Human Molecular Genetics

2010

198

Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract

Junji Xing, Leiyun Weng, Bin Yuan,

Nature Immunology

2016

198

Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells

Twee Tsao, Yuexi Shi, Steven M. Kornblau,

Annals of Hematology

2012

168

Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

Olga Frolova, Ismael Samudio, Juliana M. Benito,

Cancer Biology & Therapy

2012

124

Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104

Juliana Benito, Yuexi Shi, Barbara Szymanska,

PLoS ONE

2011

120

Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

Marina Konopleva, Roland B. Walter, Stefan Faderl,

Clinical Cancer Research

2014

83

Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models

Juliana Benito, Marc S. Ramirez, Niki M. Zacharias,

Clinical Cancer Research

2015

72

DHX15 Senses Double-Stranded RNA in Myeloid Dendritic Cells

Hongbo Lu, Ning Lü, Leiyun Weng,

The Journal of Immunology

2014

68

A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Naval Daver, Yanis Boumber, Hagop M. Kantarjian,

Clinical Cancer Research

2015

67

Page 1